Bimzelx (Bimekizumab)

Bimzelx (Bimekizumab) is a biologic medicine that suppresses the immune system in order to treat psoriatic arthritis, ankylosing spondylitis, and psoriasis.

Bimzelx works by blocking interleukin-17 (IL-17), a signalling protein (cytokine) that regulates the immune system and is related to the body's inflammatory response.

Taking Bimzelx

Bimzelx is available as a subcutaneous (under the skin) injection.

The manufacturer of Bimzelx offers a support program to Canadian patients that are prescribed the medication:

Patient support program enrolment forms

Important Tests and Risks

Science

Safety

Drug Identification Number (DIN)

02525267 (Prefilled Syringe)

02525275 (Autoinjector)